{
  "nctId": "NCT06614361",
  "briefTitle": "Community-based Behavioral Intervention to Increase Vaccination Using MOST",
  "officialTitle": "Community-based Behavioral Intervention to Increase COVID-19 and Influenza Vaccination for African American/ Black and Latino Persons: An Optimization Randomized Controlled Trial",
  "protocolDocument": {
    "nctId": "NCT06614361",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2025-01-29",
    "uploadDate": "2025-04-08T14:41",
    "size": 846507,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT06614361/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "FACTORIAL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 0,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2025-04-01",
    "completionDate": "2025-04-01",
    "primaryCompletionDate": "2025-04-01",
    "firstSubmitDate": "2024-09-25",
    "firstPostDate": "2024-09-26"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria: 2) can engage in study activities in English or Spanish; 3) Black or African American or Latino/Hispanic race/ethnicity; 4) resides in New York City; 5) has received at least one dose of a COVID-19 vaccination in their lifetime but is not up-to-date on COVID-19 vaccination, defined as has not received the most recently available vaccine, confirmed with documentary evidence; 6) eligible to receive the COVID-19 vaccine (has not had anaphylaxis, myocarditis, pericarditis, or thrombosis with thrombocytopenia syndrome or other adverse effects deemed by a physician to be related to the COVID-19 vaccine) and if previously diagnosed with COVID-19, a minimum of 10 days has elapsed since last test positivity; 7) is not up-to-date on influenza vaccination defined as not yet receiving the available influenza vaccine; 8) has a phone that can be used for study participation and can receive text messages.\n\n\\-\n\nExclusion Criteria: NONE\n\n\\-",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "70 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Vaccination for COVID-19",
        "description": "Vaccination for COVID-19 with documentary evidence",
        "timeFrame": "3- and 6-months post-baseline"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "FACTORIAL"
    },
    "overallComplexityScore": 24,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:30:39.209Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}